What is the main purpose of this Merck 8-K/A filing?

The main purpose of this 8-K/A filing by Merck & Co., Inc. is to furnish information related to Schering-Plough Corporation, specifically their Investor Frequently Asked Questions and Answers dated January 25, 2008, as Exhibit 99.1. It directs investors to this external information source.

Does this filing provide new financial results or operational updates from Merck?

No, this filing does not provide new financial statements or direct operational updates from Merck. Instead, it references and furnishes investor FAQs from Schering-Plough Corporation, suggesting the information is relevant to understanding Merck's relationship or activities involving Schering-Plough.

Where can I find the Schering-Plough Investor FAQs mentioned in the filing?

The Schering-Plough Investor FAQs, dated January 25, 2008, are furnished as Exhibit 99.1 to this filing and are also available on the Schering-Plough website at www.schering-plough.com under 'investor relations/investor FAQs'.

Should I rely on the information in the Schering-Plough FAQs as current?

Investors should be cautious. Schering-Plough states they undertake no obligation to update these FAQs. Therefore, the information reflects the status as of January 25, 2008, and may not be current. It is important to note the date of the information.

MRK 8-K: Regulation FD — Jan 28, 2008

Summary

This 8-K/A filing from Merck & Co., Inc. (MRK) primarily serves as an amendment and indicates a business relationship or ongoing development with Schering-Plough Corporation. The key takeaway for investors is the reference to Schering-Plough's Investor Frequently Asked Questions and Answers (FAQs) dated January 25, 2008. While Merck is filing this, the content being furnished is from Schering-Plough, suggesting that investors interested in the strategic or operational implications of this relationship should consult the provided FAQs. Investors should note that Schering-Plough has stated they undertake no obligation to update these FAQs. Therefore, the information contained within them represents a snapshot as of January 25, 2008. The filing itself doesn't introduce new financial data or direct operational updates from Merck, but rather points to external information relevant to understanding the broader context of Merck's activities involving Schering-Plough.

Key Highlights

1Merck & Co., Inc. (MRK) filed an 8-K/A on January 27, 2008, referencing an event date of January 24, 2008.
2The filing's primary purpose is to furnish Exhibit 99.1, which contains Investor FAQs from Schering-Plough Corporation.
3The furnished Schering-Plough FAQs are dated January 25, 2008, and are accessible via Schering-Plough's investor relations website.
4This filing suggests a point of interest or ongoing interaction between Merck and Schering-Plough that warrants investor attention.
5Investors are directed to the Schering-Plough FAQs for information relevant to this disclosed relationship.
6Schering-Plough explicitly states no obligation to update the provided FAQ information.
7The filing does not contain direct financial statements or new operational disclosures from Merck, but rather references external information.